Moonyeenn Lee & Associates (MLA), now the largest talent agency on the African continent, has announced that it is opening a new office in Cape Town. The launch of a representative office in the heart of one of South Africa's premier film destinations follows fast on the heels of a recent announcement that the agency would be representing screenwriters and directors alongside the leading talent already in the stable.Issued by Moonyeenn Lee & Associates (MLA)
After 12 years of being 'The Home of the Afropolitan', we are excited to introduce our latest evolution - Kaya 959. On the Street. On the Air. Our new brand identity is about highlighting Kaya 959 as a radio station for all.Issued byKAYA 959
Kantar's Best Liked Ads celebrates South Africa's favourite TV commercials. These are the ads that have been rated as the best liked by the South African audience, who we believe to be the most important critic - the person who ultimately chooses to buy your brand or not.Issued byKantar
The South African Health Products Regulatory Authority (Sahpra) has recommended the pause on the rollout of the Johnson & Johnson (J&J) vaccine be lifted.
The country's health department put the J&J vaccine on hold, after the US’ Food and Drug Administration paused the vaccine after reports of six women, out of 6.6-milion doses administered, developed rare cerebral venous thrombosis, with low blood levels of blood platelets.
The South African Department of Health has put the Johnson & Johnson Covid-19 vaccine on hold temporarily, while it investigates a possible link between the jab and a rare blood clot disorder...
14 Apr 2021
Sahpra said in a statement that it had engaged with the J&J’s Sisonke phase 3B implementation study team and Janssen Pharmaceutica to discuss the safety of the vaccines as well as the adverse findings reported in the US.
“Based on their review of the available data, Sahpra has recommended that the pause in the Sisonke study be lifted, provided that specific conditions are met.”
Healthcare workers participating in the Sisonke study will also be informed about the possible risks of developing a blood clotting disorder after vaccination.
“They will also be advised to seek immediate medical assistance if they develop early signs and symptoms associated with blood clots or low platelet counts. The study team will submit the required updated documents, procedures and study arrangements to Sahpra for approval.”
LEGAL DISCLAIMER: This Message Board accepts no liability of legal consequences that arise from the Message Boards (e.g. defamation, slander, or other such crimes). All posted messages are the sole property of their respective authors. The maintainer does retain the right to remove any message posts for whatever reasons. People that post messages to this forum are not to libel/slander nor in any other way depict a company, entity, individual(s), or service in a false light; should they do so, the legal consequences are theirs alone. Bizcommunity.com will disclose authors' IP addresses to authorities if compelled to do so by a court of law.